4.7 Review

Human Lung Mast Cells: Therapeutic Implications in Asthma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Allergy

Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study

Diego Alvarado et al.

Summary: In this study, CDX-0159, an anti-KIT monoclonal antibody, was found to effectively suppress MCs and showed safety and long antibody exposure in healthy volunteers. Importantly, CDX-0159 also demonstrated dose-dependent profound suppression of plasma tryptase, indicating systemic MC suppression or ablation.

ALLERGY (2022)

Article Biochemistry & Molecular Biology

Neutrophil Extracellular Traps, Angiogenesis and Cancer

Remo Poto et al.

Summary: Human neutrophils play a significant role in the host response against pathogens, and recent research has revealed their functional plasticity and involvement in cancer and angiogenesis. Neutrophils release angiogenic factors and form NETs, which promote tumor growth and metastasis through various mechanisms. Understanding the functions of NETs in cancer and angiogenesis could be important for early diagnosis, prevention, and treatment of tumors.

BIOMEDICINES (2022)

Article Respiratory System

The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)

Asger Sverrild et al.

Summary: This study demonstrates that tezepelumab can decrease airway hyperresponsiveness and airway inflammation in patients with symptomatic asthma on maintenance treatment with inhaled corticosteroids.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Allergy

Selected recent advances in understanding the role of human mast cells in health and disease

Francesca Levi-Schaffer et al.

Summary: With the advancement of research technologies and methodologies, there has been an increased understanding of the origin, development, function, and interactions of human mast cells. The potential contribution of mast cells to disease has led to the development of novel therapeutic approaches.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?

Peter Valent et al.

Summary: Mast cell activation plays a crucial role in allergic reactions, inflammatory states, and mast cell activation syndromes. While there is currently no treatment approach to eradicate mast cells, long-term use of drugs that inhibit KIT function may lead to a decrease in tissue mast cells and improvement in symptoms. For patients with KIT D816V-positive mastocytosis, effective KIT inhibitors like avapritinib may be used for mast cell eradication, but potential side effects need to be considered.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

KIT as a master regulator of the mast cell lineage

Mindy Tsai et al.

Summary: The discovery of the cell surface receptor KIT and its ligand, stem cell factor (SCF), in 1987/1988 and 1990 has greatly contributed to our understanding of the development and function of various cell lineages. Mutations in KIT or SCF can have significant effects on the development and/or function of hematopoietic progenitors, melanocytes, germ cells, and mast cells. The biological importance of KIT in other cell types is still not well understood.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022

Michel Arock et al.

Summary: This review discusses the diagnosis and prognostication of mast cell neoplasms, focusing on clinically relevant germline and somatic gene variants. The authors propose a diagnostic algorithm that combines genetic markers, clinical and histopathologic criteria to establish the diagnosis and prognosis in systemic mastocytosis (SM).

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Immunology

IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells

Remo Poto et al.

Summary: Release of proinflammatory mediators and cytokines from basophils and mast cells mediated by IgE is a key event in allergic disorders. The presence and functional activity of anti-IgE autoantibodies in atopic dermatitis (AD) are largely unknown. This study evaluated the ability of IgG anti-IgE from patients with AD to induce in vitro IgE-dependent activation of basophils and mast cells.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Differential Effects of Alarmins on Human and Mouse Basophils

Adriana R. Gambardella et al.

Summary: Epithelial-derived alarmins, IL-33, TSLP, and IL-25, play a crucial role in the development of asthma. Basophil-derived cytokines are important components of allergic inflammation. This study explored the effects of IL-33, TSLP, IL-25, and IL-3 on basophils, and found that IL-3 and IL-33 can induce the release of cytokines from human basophils, while TSLP and IL-25 have limited effects. IL-3 and IL-33 also have synergistic effects on cytokine release. The study also revealed differences between human and mouse basophils in their response to IL-3 and alarmins.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells

Piper A. Robida et al.

Summary: Mast cells are tissue-resident cells that contribute to allergic diseases through excessive or inappropriate cellular activation and degranulation. Siglec-6, a receptor selectively expressed by mast cells, could be a promising target for therapeutic intervention. This study found that Siglec-6 is highly expressed by human mast cells and has a potent inhibitory effect on mast cell activation, making it a potential therapeutic target for mast cell-driven diseases.
Review Cell Biology

The Role of Airway Epithelial Cell Alarmins in Asthma

Christiane E. Whetstone et al.

Summary: The airway epithelium is the first line of defense for the lungs, detecting environmental threats and releasing alarmin cytokines that play important roles in inflammation. Blockade of TSLP and IL-33 is beneficial for asthma treatment, but further research is needed to determine which subsets of asthma patients will benefit the most from anti-alarmin therapy.
Review Allergy

Biologics and airway remodeling in severe asthma

Gilda Varricchi et al.

Summary: Asthma is a chronic inflammatory airway disease that can result in irreversible airflow obstruction. Biologics have been shown to improve airflow obstruction and possibly reverse fixed remodeling. Therefore, analyzing the therapeutic effects of biologics in severe asthma, both early and late, is crucial.

ALLERGY (2022)

Review Immunology

Biology of lung macrophages in health and disease

Helena Aegerter et al.

Summary: This article describes how single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics can be used to separate and study different subpopulations of lung macrophages, as well as their importance and complexity in lung homeostasis and disease. It also discusses how lung macrophages undergo functional changes in different tissue states.

IMMUNITY (2022)

Review Allergy

Biologics for allergic and immunologic diseases

Hideaki Morita et al.

Summary: Biologics or molecularly targeted drugs are highly effective and relatively safe for the treatment of allergic and immunologic diseases. Recent clinical trials have demonstrated their effectiveness and revealed unexpected findings, contributing to an improved understanding of the pathophysiology of these disorders.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis

Tahereh Derakhshan et al.

Summary: This article provides an overview of the differentiation and characteristics of mast cell (MC) progenitors, as well as the heterogeneity of MCs in health and disease. Single-cell profiling technologies offer a powerful approach to decipher complex cellular functions and interactions, and to identify candidate factors for targeted therapies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Immunology

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

Wouter Korver et al.

Summary: This study reveals the inhibitory effect of Siglec-8 mAb on MC activity. Siglec-8 regulates Fc epsilon RI-induced phosphorylation events through phosphatase recruitment and interaction with Fc epsilon RI gamma, resulting in global inhibition of MCs.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases

Pavel Kolkhir et al.

Summary: The discussion focuses on the crucial roles of human mast cells in allergic and other inflammatory diseases, as well as the current and emerging therapies targeting mast cells. These therapies include monoclonal antibodies, small molecules, and other approaches to inhibit mast cell function in disease settings.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Immunology

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation

Julia Schanin et al.

Summary: Studies have shown that therapeutic treatment with anti-Siglec-8 monoclonal antibody can inhibit mast cell activation, reduce recruitment of immune cells and airway inflammation, and alleviate lung fibrosis in non-allergic disease models. Additionally, anti-Siglec-8 treatment can also suppress neutrophil influx and cytokine production by inhibiting mast cell activation.

MUCOSAL IMMUNOLOGY (2021)

Article Immunology

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic

Jeffrey R. Strich et al.

Summary: Neutrophil extracellular traps (NETs) play a role in immunothrombosis and mortality in COVID-19. The study demonstrates that R406 can inhibit NETs release and possibly mitigate neutrophil-associated mechanisms contributing to COVID-19 immunopathogenesis.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Critical Care Medicine

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim W. Harrison et al.

Summary: The study aimed to evaluate the efficacy of benralizumab in severe eosinophilic asthma patients, including onset of effect, impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms. Results showed that benralizumab significantly reduced exacerbation risk and improved HRQOL, lung function, and nasal symptoms early in the treatment period compared to placebo.

LANCET RESPIRATORY MEDICINE (2021)

Article Cell Biology

IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors

Leonardo Cristinziano et al.

Summary: The study found that immunoglobulin superantigens protein A and protein L can induce rapid release of histamine from HLMCs, while IL-33 does not trigger histamine release from lung mast cells. Prolonged incubation of HLMCs with superantigens and IL-33 leads to the release of VEGF-A and VEGF-C. Preincubation with IL-33 enhances the superantigenic release of histamine, angiogenic and lymphangiogenic factors from HLMCs.
Article Biochemistry & Molecular Biology

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells

Sijin Cheng et al.

Summary: This study conducted a pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types, revealing distinct features of TIMs in different cancer types. For example, mast cells in nasopharyngeal cancer were associated with better prognosis, and pro-angiogenic TAMs showed diverse markers across different cancer types. The composition of TIMs appeared to be linked with certain features of somatic mutations and gene expressions.
Article Biochemistry & Molecular Biology

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Jason Gotlib et al.

Summary: The study evaluated the efficacy of avapritinib in patients with AdvSM and demonstrated high rates of clinical, morphological, and molecular responses with good tolerability.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Daniel J. DeAngelo et al.

Summary: The study evaluated the efficacy and safety of avapritinib in patients with AdvSM. Results showed that avapritinib induced deep and durable responses in patients at the recommended dose, demonstrating good tolerability.

NATURE MEDICINE (2021)

Article Allergy

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab

Donald MacGlashan et al.

Summary: This study examined changes in basophil function and its relationship to auto-antibodies during treatment with omalizumab in patients with chronic spontaneous urticaria (CSU). Results suggest that the presence of auto-antibodies may affect basophil numbers and function in patients treated with omalizumab.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Medicine, General & Internal

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

Michael E. Wechsler et al.

Summary: The study found that the monoclonal antibody itepekimab targeting interleukin-33 was more effective than placebo in improving lung function and reducing the incidence of loss of asthma control events in patients with moderate-to-severe asthma.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial

Christopher E. Brightling et al.

Summary: In a study involving adults with severe asthma, inhibition of interleukin-23 signaling with the monoclonal antibody risankizumab resulted in worse asthma outcomes than placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Stem Cell Factor Neutralization Protects From Severe Anaphylaxis in a Murine Model of Food Allergy

Catherine Ptaschinski et al.

Summary: Food allergy is a growing public health concern affecting approximately 15 million people in the United States. Targeting a specific isoform of stem cell factor (SCF248) with a monoclonal antibody in a model of food allergy has shown to reduce mast cell mediated disease activation and symptoms of anaphylaxis, indicating a potential therapeutic approach for alleviating food allergy severity.

FRONTIERS IN IMMUNOLOGY (2021)

Review Allergy

Biologics for the Use in Chronic Spontaneous Urticaria: When and Which

Marcus Maurer et al.

Summary: The guidelines recommend the use of omalizumab in antihistamine-refractory CSU, highlighting the key role of IgE and FcεRI in the pathogenesis. The review covers mechanisms of action, biomarkers, and strategies for improving treatment efficacy, as well as exploring off-label use of other biologics. Future directions include novel biologics targeting various pathways in CSU treatment.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Immunology

Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation

Daniel F. Dwyer et al.

Summary: A comprehensive analysis of human MC hyperplasia in CRSwNP, a T2 cytokine-mediated inflammatory disease, was conducted using flow cytometry and single-cell RNA-sequencing. The study revealed distinct inflammation-associated effector programs of MCs, indicating that in situ MC proliferation is a major component of MC hyperplasia in human T2 inflammation.

SCIENCE IMMUNOLOGY (2021)

Article Allergy

Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial

Irene E. Braithwaite et al.

Summary: The study showed that GDC-0214 can effectively reduce fractional exhaled nitric oxide levels in patients with mild asthma, with a dose-dependent effect. Additionally, higher plasma exposure was associated with greater reduction in FENO.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

Steven G. Kelsen et al.

Summary: The study evaluated the efficacy and safety of Astegolimab in patients with severe asthma, showing that the drug reduced asthma exacerbation rate and had a good effect on patients with low blood eosinophils, while maintaining safety and tolerability.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Medicine, General & Internal

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies-Gow et al.

Summary: Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin, effectively reduces asthma exacerbations in patients with severe, uncontrolled asthma, leading to improved lung function, asthma control, and quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma

Hsin-Kuo Ko et al.

Summary: Past severe asthma exacerbations, baseline blood eosinophil counts, serum tryptase, and TSLP levels independently predict the future risk of exacerbations. High blood eosinophil counts and low serum tryptase levels are associated with a higher likelihood of future asthma exacerbations.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages

Barbara Balestrieri et al.

Summary: Two subpopulations of pulmonary macrophages were separated from human lung parenchyma based on density gradients, with high-density macrophages (HDMs) and low-density macrophages (LDMs) exhibiting differences in characteristics and responses to lipopolysaccharide (LPS). These distinct subpopulations of macrophages are likely to play different roles in lung inflammation and immune responses.

BIOMEDICINES (2021)

Article Critical Care Medicine

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

Sarah Diver et al.

Summary: Tezepelumab demonstrates efficacy in reducing airway eosinophil counts and improving airway hyperresponsiveness in patients with severe uncontrolled asthma, regardless of baseline blood eosinophil count.

LANCET RESPIRATORY MEDICINE (2021)

Article Cell Biology

Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment

Mariantonia Braile et al.

Summary: TSLP is a pleiotropic cytokine that exerts its biological effects by binding to receptors and has been implicated in the induction and progression of various cancers. The TSLP system, expressed in lung macrophages, could play a role in chronic inflammatory disorders including lung cancer.
Article Physiology

Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease

Andrew Rasky et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Article Allergy

A Phase 2a Study of DP2 Antagonist GB001 for Asthma

Koichiro Asano et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Review Immunology

Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns

Stephen J. Galli et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Letter Allergy

Benralizumab strongly reduces blood basophils in severe eosinophilic asthma

Marek Lommatzsch et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2020)

Article Medicine, General & Internal

Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2in Ischemic and Non-Ischemic Heart Failure

Gilda Varricchi et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Medicine, Research & Experimental

Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis

Melanie C. Dispenza et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, General & Internal

A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries

Shalender Bhasin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis

Evan S. Dellon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Mass Cytometry Phenotyping of Human Granulocytes Reveals Novel Basophil Functional Heterogeneity

Nora Vivanco Gonzalez et al.

ISCIENCE (2020)

Article Multidisciplinary Sciences

Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge

Henry R. Maun et al.

NATURE COMMUNICATIONS (2020)

Article Allergy

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Thomas B. Casale et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Allergy

Circulating mast cell progenitors correlate with reduced lung function in allergic asthma

Maya Salomonsson et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2019)

Article Allergy

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Peter Valent et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Review Allergy

Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019

Gilda Varricchi et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Superantigenic Activation of Human Cardiac Mast Cells

Gilda Varricchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Neurosciences

Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function

Gilda Varricchi et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Article Pharmacology & Pharmacy

Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma

Giancarlo Marone et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Review Biochemistry & Molecular Biology

Future Needs in Mast Cell Biology

Gilda Varricchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma

Henry R. Maun et al.

Article Medicine, Research & Experimental

Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling

Matthew C. Altman et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Critical Care Medicine

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

Paul A. Reyfman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Pharmacology & Pharmacy

Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives

Giancarlo Marone et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Review Allergy

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Thomas Werfel et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis

Ernest Duaha et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Immunology

Elevated levels of interleukin-33 are associated with allergic and eosinophilic asthma

Edita Gasiuniene et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)

Review Pharmacology & Pharmacy

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

Giancarlo Marone et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Medicine, Research & Experimental

Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy

Sharon Chinthrajah et al.

JCI INSIGHT (2019)

Review Immunology

Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family

Corinne Cayrol et al.

IMMUNOLOGICAL REVIEWS (2018)

Review Immunology

Human mast cells and basophils-How are they similar how are they different?

Gilda Varricchi et al.

IMMUNOLOGICAL REVIEWS (2018)

Article Dermatology

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII

A. Wollenberg et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Medicine, General & Internal

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

M. Castro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Immunology

Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer

Gilda Varricchi et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Allergy

A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma

Alexa P. Kollmeier et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

Article Pharmacology & Pharmacy

Histamine H4 receptor mediates chemotaxis of human lung mast cells

Linda J. Kay et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting

Merav Cohen et al.

Article Respiratory System

TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast

Liuzhao Cao et al.

EXPERIMENTAL LUNG RESEARCH (2018)

Article Dermatology

Controversial role of mast cells in skin cancers

Gilda Varricchi et al.

EXPERIMENTAL DERMATOLOGY (2017)

Article Allergy

IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level

Regis Joulia et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Immunology

Skin-derived TSLP systemically expands regulatory T cells

Theresa M. Leichner et al.

JOURNAL OF AUTOIMMUNITY (2017)

Article Immunology

Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation

Krishan D. Chhiba et al.

JOURNAL OF IMMUNOLOGY (2017)

Article Medicine, General & Internal

KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma

Katherine N. Cahill et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medical Laboratory Technology

Skin microbiome and mast cells

Satomi Igawa et al.

TRANSLATIONAL RESEARCH (2017)

Article Allergy

Real-life Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis

Abdulaziz Alhossan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)

Article Critical Care Medicine

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma

Ann Esquivel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Review Medicine, General & Internal

Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer

Maria Rosaria Galdiero et al.

FRONTIERS IN MEDICINE (2017)

Review Immunology

Mast cells in rheumatoid arthritis: friends or foes?

Felice Rivellese et al.

AUTOIMMUNITY REVIEWS (2017)

Article Biochemistry & Molecular Biology

The modulatory effect of TLR2 on LL-37-induced human mast cells activation

Yuan-Yuan Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Pharmacology & Pharmacy

The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma

A. L. da Silva et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Review Allergy

Mast cells in asthma - state of the art

P. Bradding et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2016)

Article Pharmacology & Pharmacy

Mast cell proteases as pharmacological targets

George H. Caughey

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Review Allergy

Are Basophils and Mast Cells Masters in HIV Infection?

Gianni Marone et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy

Glenn Cruse et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange

Luke F. Pennington et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer

A. Shikotra et al.

SCIENTIFIC REPORTS (2016)

Article Immunology

Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33

Geethani Bandara et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2015)

Article Allergy

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis

Hyun-Woo Shin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Allergy

Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis

Shunya Mashiko et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Review Cardiac & Cardiovascular Systems

Mast cells in human and experimental cardiometabolic diseases

Guo-Ping Shi et al.

NATURE REVIEWS CARDIOLOGY (2015)

Article Medicine, General & Internal

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Pharmacology & Pharmacy

A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response

Isabel Ramis et al.

PHARMACOLOGICAL RESEARCH (2015)

Letter Allergy

Siglec-7 is an inhibitory receptor on human mast cells and basophils

Sa'ar Mizrahi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Article Medicine, General & Internal

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Elisabeth H. Bel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Hector G. Ortega et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

Sally Wenzel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Allergy

Contribution of stress to asthma worsening through mast cell activation

Theoharis C. Theoharides et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2012)

Article Dermatology

Expressions and inhibitory functions of CD300a receptors on purified human basophils

Bernhard F. Gibbs et al.

EXPERIMENTAL DERMATOLOGY (2012)

Article Allergy

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy

Jessica H. Savage et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Allergy

Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma

Aarti Shikotra et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Gastroenterology & Hepatology

Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy

K. Vaali et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2012)

Review Pharmacology & Pharmacy

Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions

Takumi Kiwamoto et al.

PHARMACOLOGY & THERAPEUTICS (2012)

Review Dermatology

Mast Cells as Regulators of Skin Inflammation and Immunity

Ilkka T. Harvima et al.

ACTA DERMATO-VENEREOLOGICA (2011)

Article Medicine, General & Internal

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial

Nicola A. Hanania et al.

ANNALS OF INTERNAL MEDICINE (2011)

Review Immunology

Basophils: emerging roles in the pathogenesis of allergic disease

John T. Schroeder

IMMUNOLOGICAL REVIEWS (2011)

Article Allergy

Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses

Chris J. Corrigan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Multidisciplinary Sciences

TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation

Mark C. Siracusa et al.

NATURE (2011)

Article Medicine, General & Internal

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

William W. Busse et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Allergy

Angiogenesis and lymphangiogenesis in bronchial asthma

A. Detoraki et al.

ALLERGY (2010)

Article Immunology

Mast Cell Fibroblastoid Differentiation Mediated by Airway Smooth Muscle in Asthma

Davinder Kaur et al.

JOURNAL OF IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Mast cells have a protumorigenic role in human thyroid cancer

R. M. Melillo et al.

ONCOGENE (2010)

Article Multidisciplinary Sciences

IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation

Chia-Lin Hsu et al.

PLOS ONE (2010)

Article Multidisciplinary Sciences

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

Theoharis C. Theoharides et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Critical Care Medicine

A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma

Sally E. Wenzel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Review Peripheral Vascular Disease

The role of the Angiopoietins in vascular morphogenesis

Markus Thomas et al.

ANGIOGENESIS (2009)

Article Respiratory System

FcεRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells

Y. Okayama et al.

EUROPEAN RESPIRATORY JOURNAL (2009)

Article Allergy

Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects

Aikaterini Detoraki et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Editorial Material Dermatology

Mast Cell Stabilizing Properties of Antihistamines

Francesca Levi-Schaffer et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

Article Medicine, General & Internal

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Allergy

Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma

Sarah J. Ballantyne et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Article Medicine, Research & Experimental

IL-33 can promote survival, adhesion and cytokine production in human mast cells

Motoyasu Iikura et al.

LABORATORY INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation

Merel C. M. Strik et al.

MOLECULAR IMMUNOLOGY (2007)

Review Allergy

Proximal signaling events in Fc epsilon RI-mediated mast cell activation

Taku Kambayashi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Review Pharmacology & Pharmacy

Stem cell factor expression, mast cells and inflammation in asthma

CA Da Silva et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)

Article Allergy

Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a

Ido Bachelet et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Article Immunology

The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast

I Bachelet et al.

JOURNAL OF IMMUNOLOGY (2005)

Article Allergy

IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure:: Effect of immunotherapy

KT Nouri-Aria et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)

Article Biochemistry & Molecular Biology

A chimeric human-cat fusion protein blocks cat-induced allergy

DC Zhu et al.

NATURE MEDICINE (2005)

Article Allergy

Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts

SW Wang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)

Article Allergy

Omalizumab-induced reductions in mast cell FcεRI expression and function

LA Beck et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

Article Allergy

Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein

K Zhang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

Article Allergy

Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3

M Kulka et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

Article Pharmacology & Pharmacy

Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells

CL Hofstra et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Article Critical Care Medicine

Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone

A Chetta et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Medicine, General & Internal

Mast-cell infiltration of airway smooth muscle in asthma

CE Brightling et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Allergy

Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils

KK Kikly et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)